Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy

KR Crews, AA Monte, R Huddart… - Clinical …, 2021 - Wiley Online Library
Opioids are mainly used to treat both acute and chronic pain. Several opioids are
metabolized to some extent by CYP2D6 (codeine, tramadol, hydrocodone, oxycodone, and …

Trends in tramadol: pharmacology, metabolism, and misuse

K Miotto, AK Cho, MA Khalil, K Blanco… - Anesthesia & …, 2017 - journals.lww.com
Tramadol is a unique analgesic medication, available in variety of formulations, with both
monoaminergic reuptake inhibitory and opioid receptor agonist activity increasingly …

Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology

RA Swarm, JA Paice, DL Anghelescu, M Are… - Journal of the National …, 2019 - jnccn.org
In recent years, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for
Adult Cancer Pain have undergone substantial revisions focusing on the appropriate and …

Guidelines for monitoring and management of pediatric patients before, during, and after sedation for diagnostic and therapeutic procedures

CJ Coté, S Wilson… - …, 2019 - publications.aap.org
The safe sedation of children for procedures requires a systematic approach that includes
the following: no administration of sedating medication without the safety net of …

Guidelines for monitoring and management of pediatric patients before, during, and after sedation for diagnostic and therapeutic procedures: update 2016

CJ Cote, S Wilson… - …, 2016 - publications.aap.org
The number of diagnostic and minor surgical procedures performed on pediatric patients
outside of the traditional operating room setting has increased in the past several decades …

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update

KR Crews, A Gaedigk… - Clinical …, 2014 - Wiley Online Library
Codeine is bioactivated to morphine, a strong opioid agonist, by the hepatic cytochrome
P450 2D6 (CYP2D6); hence, the efficacy and safety of codeine are governed by CYP2D6 …

[HTML][HTML] Basic review of the cytochrome p450 system

AM McDonnell, CH Dang - Journal of the advanced practitioner in …, 2013 - ncbi.nlm.nih.gov
Basic Review of the Cytochrome P450 System - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II

SF Zhou - Clinical pharmacokinetics, 2009 - Springer
Part I of this article discussed the potential functional importance of genetic mutations and
alleles of the human cytochrome P450 2D6 (CYP2D6) gene. The impact of CYP2D6 …

Opioid metabolism

HS Smith - Mayo Clinic Proceedings, 2009 - Elsevier
Clinicians understand that individual patients differ in their response to specific opioid
analgesics and that patients may require trials of several opioids before finding an agent that …

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects

M Ingelman-Sundberg, SC Sim, A Gomez… - Pharmacology & …, 2007 - Elsevier
The polymorphic nature of the cytochrome P450 (CYP) genes affects individual drug
response and adverse reactions to a great extent. This variation includes copy number …